RPS Annual Review 2024

A message from RPS President Professor Claire Anderson and CEO Paul Bennett

Paul Bennett, RPS CEOProf Claire Anderson, RPS President

Welcome to the Royal Pharmaceutical Society (RPS) Annual Review of 2024 – a year of progress, successes and change, set against the backdrop of a fast-changing pharmacy landscape.

2024 saw our 18-month-long constitution and governance review, which focused on how RPS can best fulfil its leadership role, come to fruition. In September 2024 the RPS’ governing body, the Assembly, together with the RPS senior leadership, announced proposals for significant change to our structure and governance including the registration of the organisation as a charity and seeking to become a royal college, the Royal College of Pharmacy. As part of the proposals the RPS’s knowledge business, Pharmaceutical Press would become a wholly owned subsidiary.

The proposed transition to a Royal College aims to establish a stronger and more collaborative leadership body that can better deliver its strategic ambitions. Central to these proposals was and is enhancing and developing RPS core activities including in education, credentialling, standards and guidance, to the benefit of patients and the public.

In October and November 2024 we went ‘on the road’ to set out the details of the proposed changes to members and non-members and gather their views and opinions. The results of the conversations and feedback of both the roadshow and related online events were published in the Roadshow Report in December 2024.

At the time of writing, the results of the Special Resolution Vote (SRV) held in March 2025 are known and RPS members voted in support of the proposed changes.

See: Change Proposals, Roadshow Report and the Constitution & Governance section below.

In March 2024 we announced a new GB-wide project to examine the causes of the growing challenge of medicines shortages and help tackle their impact on patients and pharmacy practice. We were delighted that RPS Fellow Dr Bruce Warner agreed to chair the new advisory group, which brought together experts from primary and secondary care, patients, the pharmaceutical industry, suppliers, regulators, government and the NHS. The resultant RPS report, Medicines Shortages: Solutions for Empty Shelves, was published in November 2024 and highlighted systemic issues while proposing actionable solutions.
See: Medicines Shortages

We provided a considered response to the UK COVID-19 Inquiry as a designated Core Participant; offering insights into the vital role of pharmacists and pharmacy during the pandemic. See: RPS presents evidence at UK COVID-19 inquiry hearing

We continued our advocacy work across the three nations, championing pharmacy’s role in palliative care, the need for more focus on workforce wellbeing and for protected learning time.

As the UK prepared for a General Election, we launched our RPS Manifesto, which detailed key asks to ensure pharmacy was prioritised in future health policy by the winning party.

In October, we also published our position on Assisted Dying. This was one of the most ethically significant debates in modern healthcare, and our thoughtful contribution was well-received.
See: Assisted Dying policy

We continued to provide high quality support for pharmacy practice, including the publication of the Repeat Prescribing Toolkit, in partnership with Royal College of General Practitioners and as commissioned by NHS England.

We discussed key topics and gathered evidence, supported by our specialist science and research team, to inform updates to policies and guidance, including a systematic review of evidence related to the Facilitated Self-Selection of P-Medicines, and provided a robust consultation response on supervision. All of this work aimed to support safe, efficient, and patient-centred pharmacy practice.
See:

We continued to play a full and active role in the UK Pharmacy Professional Leadership Advisory Board (UKPPLAB) and to collaborate across the different pharmacy bodies and groups, to help strengthen pharmacy leadership. We firmly believe that by working together, pharmacy can enhance its leadership capabilities and better serve the needs of patients, professionals, and the public.

RPS’ knowledge business Pharmaceutical Press, continued to innovate and develop. In a strategic move to support digital innovation in the safe and effective use of medicines, RPS, on behalf of PhP, invested in Dosium, a healthtech start-up with the potential to transform clinical decision support, with indication-based prescribing that puts BNF and BNF for Children at the centre of electronic prescribing. RPS makes landmark investment in Dosium

Taken together, we believe all of these initiatives demonstrate our ongoing dedication to advancing pharmacists to provide excellence in patient care, influencing health and medicines policy, championing the science and research that underpins professional practice and supporting our members. We are proud of what we have achieved in 2024 and remain relentlessly focused on advancing our mission of putting pharmacy at the forefront of patient care.

Paul Bennett
RPS Chief Executive

Professor Claire Anderson
RPS President

 

2024 in numbers...

879,447 visitors to rpharms.com

137 events delivered 11,985 attendees at RPS events 16 roadshows about royal college proposals 185 research and innovation posters at conference 3,882,118 social media post views 9.2% increase in social media followers 121 news stories on rpharms.com 4,000+ mentions of RPS in the media 107,000+ people read RPS news stories almost 16,000 read RPS blogs 122 pharmacists credentialed 3,632 enquiries to RPS Professional Support Teams 108 vital Pharmacy Alerts sent 32,860 visits to the RPS e-Library 850 pharmacists in Wales attended the RPS PIPS programme29 universities reached by the RPS Engagement Team 131 new mentors signed up

Constitution & Governance

Paul Bennett presents a Scottish audience about C&GAt the start of 2023 RPS commissioned an independent in-depth review of our governance and constitution, carried out by a specialist agency, Firetail. Based on this 18-month-long review process and following a unanimous decision from the RPS Assembly, in March 2024 and again in July 2024, draft proposals for change were shared in September 2024.

The proposals set out RPS’ ambition to become a royal college, and changes to its structure and Royal Charter including seeking to become a charity, and creating a wholly owned (limited) subsidiary for publishing activities. The proposed changes reflected an accepted model for royal colleges and a modernised corporate structure, to better support RPS’ professional leadership activities and ambition.

In October and November 2024 RPS held a series of engagement events and roadshows across GB and online, to talk with pharmacists and pharmaceutical scientists (whether members or not) about these proposed changes. The discussions and feedback that took place during these roadshow events can be read in detail in the Roadshow Report.

In order to progress with these proposals, charter change was required. In February 2025 the proposed changes to RPS’ Royal Charter and details of an all-member Special Resolution Vote (SRV) were published.

A successful outcome to the Special Resolution was just one of a number of steps required to change the RPS Royal Charter, transition to charity status and become the Royal College of Pharmacy. At the time of publishing this 2024 Annual Review, RPS has shared its commitments as a royal college and was continuing dialogue with both the Privy Council Office and the charity regulators in England, Wales, and Scotland. It moved into a formal process in the second half of the year. 2025. 

The aim is to complete the transition to royal college status by Spring 2026.

Policy & Advocacy across Great Britain

Through our policy and advocacy work, RPS puts pharmacy at the centre of the complex and ever-changing health policy landscape. We play a leading role in ensuring pharmacy has a presence at the highest levels of decision-making across Great Britain and its constituent nations.

Health policy is devolved to national governments within the UK. The RPS policy and advocacy team is made up of three national offices which work closely with parliamentarians at Westminster, Holyrood and the Senedd, civil servants, health and care systems leaders, regulators and civil society.  

In 2024, the RPS undertook significant initiatives to advance the pharmacy profession across GB and internationally. These efforts focused on addressing critical issues such as medicines shortages, workforce wellbeing, policy development, and global collaboration.

Medicines Shortages
Cover of the RPS report into Medicines ShortagesThe RPS developed a national strategy to manage shortages, and published the report Medicines Shortages: Solutions for Empty Shelves, examining the causes and impacts of shortages, and offering recommendations such as implementing legislative changes to allow pharmacists to amend prescriptions during shortages.

The report was launched at the House of Commons on 27 November 2024, with subsequent briefings at the Scottish Parliament and the Senedd.

An advisory group comprising 20 members from across the supply chain and patient representatives supported the report's development. A patient survey gathered 123 responses to understand experiences related to obtaining medicines.

Policy and Advocacy
Events were held in the parliaments of England, Scotland, and Wales to launch the medicines shortages report and discuss its recommendations.

A new policy was published outlining how artificial intelligence can support pharmacy practice and enhance patient care.

The RPS submitted evidence to the UK COVID-19 Inquiry, emphasizing lessons on pharmacist recognition in national policy, pharmacy service resilience, medicines shortages, and pharmacy team welfare.

Workforce Wellbeing
In response to the annual workforce wellbeing survey, the RPS hosted a roundtable with Pharmacist Support, bringing together key stakeholders to address issues such as burnout and lack of time for professional development.

For the first time, the RPS Workforce Wellbeing Survey included pharmacy technicians, and revealed that 87% of the pharmacy workforce was at risk of burnout.

Country Highlights

England
RPS submitted evidence to the Darzi Review of the NHS in England and contributed to the 10-Year Health Plan ‘Partners Council’, advocating for key pharmacy issues.
Evidence was provided to MPs scrutinising assisted dying legislation and supporting pharmacists' right to conscientious objection.

The RPS co-signed a letter to the Secretary of State for Health and Social Care with other organisations, calling for a cross-government strategy to tackle medicine shortages.
RPS supported the Pharmacy All-Party Parliamentary Group, engaging with MPs and Peers on issues like medicines shortages and the future of pharmacy.

RPS launched a Westminster general election manifesto, highlighting issues such as patient safety, access to medicines, technological advancements, and workforce pressures.

Scotland
RPS provided comprehensive evidence to the Health, Social Care and Sport Committee on the Assisted Dying for Terminally Ill Adults (Scotland) Bill

Research conducted by the RPS into community pharmacists’ access to patient records, and the findings were published in The Times.

A drop-in event hosted by RPS for MSPs to discuss access to patient records, reinforcing calls from the Pharmacy 2030 Vision for Scotland.

An RPS blog was published on integrating pharmacists into the NHS as part of the #NHS2048 series by Reform Scotland.

RPS visited pharmacy teams in NHS Dumfries and Galloway and NHS Shetland to observe innovative practices aligned with the 2030 Vision.

Wales
The Pharmacy: Delivering a Healthier Wales (P:DaHW) Conference was hosted by RPS, with 200 attendees exploring strategic developments and innovations aligned with the 2030 vision.

Governance for the 2030 Vision for Pharmacy in Wales for the P:DaHW Delivery Board and its working groups was provided by the RPS.

RPS engaged with the Senedd by giving oral evidence to its health committee, hosting MS visits with pharmacists, and holding quarterly briefings.

RPS launched a programme with HEIW to enhance prescribing skills across Wales, equipping pharmacists to deliver excellent patient care.

RPS Wales members participated in Cardiff Pride for the first time, reinforcing the commitment to inclusivity in the profession.

 

Science & Research

Illustration of three people doing pharmaceutical science

Scientific understanding and knowledge and is fundamental to expertise in medicines, while research skills are important for supporting the development of practice. Our science and research work supports the full spectrum of RPS activities, underpinning our evidence-led approach, and enabling RPS members to progress their practice, increase their knowledge and access the latest pharmaceutical science.

In 2024, we launched a new web-based resource to help members discover research funding opportunities, Research Funding and Developing Research Proposals, listing 50 funding opportunities and funders. Since its creation, almost 1,200 members have accessed this resource, which advertises funding opportunities for all career stages. Over 70 people joined a webinar in October, Demystifying Research Funding, to further improve access to research funding opportunities.

2024 saw RPS grow our presence at regional research events. The team attended and presented research at Health Services Research & Pharmacy Practice (HSRPP) in April, Great Northern Pharmacy Research Network (GNPRN) in July, and South West Pharmacy Research Network (SWPRN) in October.

And finally, a blog, published on our website, on the importance of using science in pharmacy practice, Application of Science by Antimicrobial Pharmacists, proved highly popular.

Professional Standards & Guidance

RPS plays a critical role developing professional standards and guidance to advance pharmacy practice and maintain patient safety across Great Britain and is driving the collaborative development of professional standards and guidance for pharmacy, underpinning care quality across a growing range of practice areas.

RPS works with our members and partners across the health and care system to create professional standards which serve as a vital foundation for practice, ensuring pharmacy is playing its part in the delivery and development of health services. Our professional standards support pharmacy teams in all settings to expand and improve their practice whilst maintaining quality and protecting patient safety.

Professional Standards
The team successfully completed and published revised editions of the RPS Professional Standards for Homecare Services and the RPS Patient Safety Incident Reporting Standards. The latter was also showcased internationally through a poster and abstract presented at the International Pharmaceutical Federation (FIP) conference. 

Additionally, a quality improvement audit of hospitals in the Swansea Bay University Health Board was carried out using the RPS Hospital Standards to benchmark performance. 

Substantive progress was made in the development of a Greener Pharmacy Toolkit, aimed at supporting environmentally sustainable practices in both community and hospital pharmacy settings.

Patient Safety
A dedicated Patient and Medicines Safety Manager was recruited to bring specialised expertise and leadership to the organisation. Relationships with key patient safety stakeholders were established and deepened through regular engagement. The RPS also enhanced its role in supporting national safety efforts by consolidating responses to Prevention of Future Deaths reports and requests from the Health and Safety Investigation Branch. 

Work also commenced on the development of a broader RPS Patient Safety Strategy, which will shape future efforts in this critical area.

Medicines, Ethics and Practice (MEP)
Green cover of the MEPJuly 2024The 47th edition of Medicines, Ethics and Practice (MEP) was fully revised and published in both print and digital formats, ensuring pharmacy professionals have access to clear, current, and practical guidance.

Professional Guidance and Education
A total of eight new Pharmacy Guides were published, and 42 existing guides were updated to reflect current practice and policy. 

Collaborative initiatives across RPS teams supported the publication of a Repeat Prescribing Toolkit by the Country Teams, the delivery of new educational content to the RPS Learning Management System by the Education Team, and the provision of a Foundation Pharmacist talk by the Engagement Team. Internationally, RPS contributed to a remote webinar on Men’s Health hosted by FIP and delivered a lecture on Prescribing and Pharmacy First at the Brazilian Congress of Pharmaceutical Science.

Education & Professional Development

RPS is a leading provider of education, training, and professional development for pharmacists, supporting pharmacists’ annual revalidation and the continued development of skills to improve practice. As the role of pharmacy expands and diversifies within the health and care system, RPS’s work in education and professional development underpins professional practice and patient safety.

Health Education and Improvement Wales (HEIW) – RPS Pharmacy Independent Prescribing Service programme
RPS and HEIW delivered a successful collaborative training programme aimed at pharmacist prescribers delivering the PIPS service in community pharmacies across Wales. Training sessions covered clinical topics including respiratory, ear, urinary tract conditions, sexual health and conditions in children. In total, 26 training sessions were held both online and face-to-face, attended by more than 850 pharmacists from Wales. The success of the programme has led to further collaboration with HEIW in 2025.

Designated Prescribing Practitioners support
RPS held an online event for prospective and new DPPs, Becoming a DPP, with the Royal College of Nursing. The event supported prescribers in becoming DPPs, addressed key considerations in the role, and provided an environment to share challenges and network with peers.

55 delegates attended, including a range of prominent speakers from clinical practice, academia, policymakers, and leadership bodies.

The RPS Barnett Award for mentoring
Photo of Professor Nina BarnettThe RPS Barnett Award was introduced in 2024, in memory of RPS Fellow Nina Barnett, who dedicated so much time to mentoring within healthcare, and helped develop the RPS mentoring programme. The award celebrates RPS members who have dedicated their careers to supporting, mentoring, and advancing others and have instilled a culture of professional development excellence within the profession. The inaugural Barnett Award received 18 submissions, and was presented to Dr Joanne Brown.

Mentoring and National Mentoring Day
In 2024, 131 new mentors and 448 new mentees joined the RPS Mentoring Programme.

RPS celebrated National Mentoring Day on Sunday, 27 October 2024, to raise awareness of our mentoring platform and highlight the benefits of mentoring to both mentees and mentors. 12 new mentors and 34 new mentees joined our programme.

NPPG Conference
In 10 November, the RPS gave a presentation, Inspiring Success, to over a hundred pharmacists who specialise in neonates and paediatrics at the Neonatal and Paediatric Pharmacy Group to raise awareness of the RPS Mentoring Platform. The platform now has specialist features to make it easier to find mentors working in paediatrics.

Foundation Trainee programme
A record-breaking 1,900 Foundation trainee pharmacist members joined the RPS to access our trainee resources.

In October, RPS implemented support for those resitting after a failed attempt at the summer GPhC registration assessment sitting, which over 160 trainees joined. The support focused on pitfalls the noted by the GPhC from the summer sitting, and tips to overcomes weaker areas which had been identified.

Students – ORIEL National recruitment Scheme
Over 620 students registered for a series of webinars RPS delivered with NHS England, NHS Education for Scotland, Health Education and Improvement Wales, and British Pharmaceutical Students' Association to support third year undergraduate students in the national foundation training recruitment scheme (Oriel).

Workshops focused on preparing students for the GB wide numeracy and situation judgement test assessments were attended by 215 students.

Credentialing

Cover of the RPS' Advanced Pharmacist Critical Care Curriculum

RPS Credentialing is designed to formally recognise and assure the capabilities of pharmacists as they advance in their professional practice.

Through the development of national UK curricula, RPS provides clear pathways for individual professional development and career progression; these have the potential to provide powerful drivers for the advancement of pharmacy practice and delivery of excellence in patient care.

This work creates an important national framework for post-registration education and training which has the potential to be integrated into NHS policy and thus inform strategic workforce planning and be reflected in pharmacist roles across the system.

In 2024, the Credentialing team organised 226 credentialing competence committees, successfully credentialed 122 pharmacists, and reviewed 30 new consultant pharmacist posts.

May, saw the first RPS post-registration Foundation pharmacists credentialed.

In September, approximately 50 pharmacists from a range of settings attended an Advanced Practice credentialing summit to examine the current status of advanced practice across the UK.

Specialist Advanced pharmacist curricula for Critical Care and Mental health were also launched:

Inclusion & Diversity

A photo of two women and a man at a university lecture

The Royal Pharmaceutical Society is committed to making inclusion and diversity central to the profession, celebrating and encouraging diverse voices across pharmacy and ensuring that all can thrive and reach their potential.

We continue to champion inclusion and diversity across pharmacy and call out where we see discrimination or unfairness, and this year was no exception.

The RPS Inclusion & Diversity team delivered national events on throughout 2024, including for International Women's Day, South Asian Heritage Month, South East Asian Heritage Month and Black History Month. This year a team from RPS also joined Cardiff Pride for the first time, celebrating the contribution of LGBTQ+ pharmacy professionals in Wales.

The RPS Action in Belonging, Culture and Diversity (ABCD) group continued to be valued, and held five meetings through 2024 for its 600 members.

The Differential Attainment Report was published, in collaboration with other pharmacy groups, looking at how best to close the degree-awarding gap and registration assessment attainment for Black trainees in initial pharmacy education and training. At CPC North team members spoke about the Report, and we hosted the first annual EDI forum in partnership with NHS WT&E and the Pharmacy Schools Council.

Membership

Membership of RPS unlocks an exceptional range of benefits to support practitioners at every stage of their professional journey, and supports pharmacists to excel in their practice. It also enables individual pharmacists and pharmaceutical scientists to play a valuable role in delivering our mission to put pharmacy at the forefront of patient care.

Expert Advisory Groups

The RPS' eight Expert Advisory Groups (EAGs) work with governments, NGOs, industry, and organisations, providing valuable advice and guidance across all sectors of pharmacy.

In 2024, following a rigorous review and alignment of their Terms of Reference, each group was officially reviewed and updated, so that the invaluable contributions of all 100-plus members could be better agreed upon and recognised. With all eight groups on a more professional footing, this will raise the profile of the RPS’ contribution to policy decisions across all three countries.

Events

Events are a vital part of the RPS membership offer, bringing together members and non-members to learn, develop and thrive. RPS events not only help keep pharmacists stay up to date on new technologies, developments and advice, but are a welcome place to network and socialise beyond the usual boundaries.

RPS events were well-attended and received throughout 2024, attracting nearly 12,000 attendees across 137 events. Feedback from participants was overwhelmingly positive: 99% rated event experiences as either "excellent" or "good," and 96% indicated they would recommend RPS events to colleagues.

Crowds talking at the RPS Annual Conference 2024The flagship event of the year was undoubtedly the RPS Annual Conference, held in London in November. This prestigious event was fully booked and welcomed 802 delegates who saw an impressive line-up of speakers, including Dr Liz O'Riordan, the UK’s Chief Pharmaceutical Officers, and numerous experts from across the profession.

As part of its commitment to professional development, the RPS Live education series ran two sessions in collaboration with the National Institute for Health and Care Excellence (NICE). Aligned with new and updated NICE guidance, these sessions, Suspected Acute Respiratory Infection and Virtual Ward Technologies, and Cardiovascular Disease and Lipid Modification, attracted over 420 members.

Additionally, 2024 saw the launch of the multi-professional Joint Royal College Safer Use of Medicines education series. The first two sessions of this four-part series focused on the topic of Human Factors, promoting interprofessional learning and improved patient safety practices.

Almost 1,600 trainees attended the RPS Foundation Trainee Revision Course and Mock Assessment, each attending seven live revision support webinars and completing two online practice assessments.

41 new webinars were added to the RPS Webinars Hub, helping members catch up at a time to suit them; and 23 RPS business meetings were also made available online, including Assembly, Country Boards, and Expert Advisory Groups.

Professional Support

For all RPS members with a professional or practice question or problem, the skilled RPS Professional Support team are available to help 9-5, Monday to Friday.

In 2024, the RPS Professional Support team responded to over 3,600 member enquiries—an average of ten per day—demonstrating the continued demand for expert guidance and support across the profession.

Throughout the year, the team also issued 108 Pharmacy Alerts, providing timely, critical information to members. These included updates on significant regulatory changes, such as the ban on the supply of puberty blockers to individuals under the age of 18.

A key development in 2024 was the launch of a dedicated prescribing support service, introduced in response to the increasing number of members seeking advice on becoming a prescriber, developing their prescribing practice, and enhancing their clinical impact. This new service underscores RPS’s commitment to supporting members at every stage of their professional journey.

Local Engagement

The RPS Engagement team helps to foster a strong sense of community and belonging among members, and showcase the work of RPS, the team works across GB and teams across RPS to set up events, visits, and presentations that provide opportunities for members to learn, share, network and engage with RPS and each other.

In 2024, the team went across GB, visiting 29 universities to exhibit at 20 careers fairs and 17 fresher's weeks, sharing all the benefits of RPS membership.

17 bespoke workshops were held, and the team delivered presentations to students on subjects including inclusion and diversity, sustainability, professional judgement and ethical decision-making.

As well as these, they attended almost 40 other events and workshops with the British Pharmaceutical Students’ Association (BPSA).

Engagement leads worked closely with regional ambassadors to plan and deliver events across GB, and the team was present at key events such as the HSJ Medicines Forum, BOPA Annual Conference, Great North Research Conference, and ConFed Expo.

RPS Library and e-Library

View of some of the sheleves at the RPS Library in LondonThe online RPS e-Library supported pharmacists 24/7 in 2024. It was visited by almost 33,000 pharmacists looking for vital reference, guides, and textbooks – all available all the time to every member. 

The library’s most regularly used e-books were Maudsley Prescribing/Deprescribing Guidelines and the Renal Drug Handbook.

Communication & Media

Media

RPS Director for England on TVThe RPS Press Office works to communicate our mission and work to stakeholders and the public by building relationships with journalists, providing expert commentary and background information, and identifying and managing media opportunities. 

During 2024 the media team engaged with and sought to harness the daily news cycle to amplify the voice of pharmacy with decision-makers, government and the public. From medicine shortages to workplace pressures and everything in-between, they showcased the impact of pharmacy professionals and the safe and effective use of medicines on TV, radio, newspapers and online.

In 2024, the RPS was mentioned over 4,000 times in the media, and there were also numerous interviews across media, including appearances on BBC’s The One Show on ADHD medicines, ITV Tonight on weight loss medicines, and BBC News on medicine shortages.

The team also published 121 news stories on the website – one every three days – and these were read by over 107,000 people. 61 new blogs were also published in 2024 – more than one each week – and these were read by over almost 16,000 people.

Both news stories and blogs set a new record for readership in 2024.

Social Media

The RPS utilises social media to support pharmacists, advocate for the profession, and engage with both members and the broader public.

RPS shared 2,974 posts across social media in 2024, and these posts were then shared more than 8,300 times by followers on LinkedIn, X (formerly Twitter), and Facebook where they were viewed almost 3,882,000 times and were commented upon 1,242 times.

Follower numbers across RPS channels were up by 9.2% in 2024 to 142,994, and views of posted videos reached 37,768. There were also 31,114 reactions to posts, 15,445 clicks on links, and 8,343 shares of RPS posts.

Top posts in 2024

LinkedIn post on 25 September 2024 for World Pharmacist Day

25 September on LinkedIn
Happy #WorldPharmacistDay! Thank you for playing a vital role in patient care and being an integral part of healthcare systems. #WPD2024
529 reactions

LinkedIn post for 12 September 2024 announcing RPS ambition to become a royal college

12 September on LinkedIn
Today, we are announcing our ambition to move to become a Royal College.
We are setting out our proposals for change following an independent, 18-month-long review of our constitution and governance.
Find out more and explore the proposals in detail: https://bit.ly/47pynri

312 reactions

Twitter post from 19 March 2024, thanking Danny Kruger MP for referencing RPS concerns during the Assistd Dying debate in Parliament

19 March on Twitter
Thank you @danny__kruger MP for referencing our concerns about conscientious objection in last night’s Assisted Dying Bill debate. We welcome the commitment by MPs to work together to ensure that all pharmacists are protected by the Bill.
186 likes

Our international work

Through its international work, RPS promotes excellence in pharmacy and patient care internationally, and fulfils an important role as a representative and champion of British pharmacy. We represent our international members and work bilaterally with pharmacy professional bodies from around the world. This work supports pharmacy and healthcare globally, but also plays a vital part in strengthening expertise and knowledge for pharmacists here, ultimately helping improve health and care outcomes for patients.

To help strengthen global ties, RPS hosted the President of the International Pharmaceutical Federation (FIP) at its London headquarters. Delegations from Japan, Singapore, and Malawi were welcomed, fostering international collaboration.

RPS also showcased British pharmacy practice at conferences in South Africa, Brazil, and Iceland.

Museum & Heritage

The RPS Museum updated its Controlled Drugs procedures in line with Home Office regulations and continued to grow its Cardiff Collection through new acquisitions and assessments. 

The Museum’s public engagement was further enhanced through filming for an upcoming episode of the BBC TV programme Inside the Factory (to be aired in 2025) and the continuation of the COVID-19 Oral History Project in partnership with the Retired Pharmacist Group. As part of its commitment to education and social responsibility, the Museum hosted five student placements and partnered with Tower Hamlets charity The Switch to provide enriching opportunities for local children.